{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:09:59Z","timestamp":1791839399939,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.xcrm.2025.101995","type":"journal-article","created":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T14:54:54Z","timestamp":1742309694000},"page":"101995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T\u00a0cell reprogramming for melanoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Wenhua","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyao","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6964-7131","authenticated-orcid":false,"given":"Mingzhu","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.101995_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jaad.2018.08.055","article-title":"Guidelines of care for the management of primary cutaneous melanoma","volume":"80","author":"Swetter","year":"2019","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"key":"10.1016\/j.xcrm.2025.101995_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc.2016.37","article-title":"From melanocytes to melanomas","volume":"16","author":"Shain","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101995_bib3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s43018-022-00382-1","article-title":"The status of tumor mutational burden and immunotherapy","volume":"3","author":"Anagnostou","year":"2022","journal-title":"Nat. Can. (Ott.)"},{"key":"10.1016\/j.xcrm.2025.101995_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.aad0095","article-title":"Genomic correlates of response to CTLA-4 blockade in metastatic melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101995_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment","volume":"59","author":"Marzagalli","year":"2019","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.xcrm.2025.101995_bib6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.101995_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.101995_bib8","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa2210233","article-title":"Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma","volume":"387","author":"Rohaan","year":"2022","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101995_bib9","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa1910836","article-title":"Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma","volume":"381","author":"Larkin","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.101995_bib10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.21.02229","article-title":"Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma","volume":"40","author":"Wolchok","year":"2022","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.101995_bib11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-pathol-042020-042741","article-title":"Immune Checkpoint Inhibitors for the Treatment of Cancer: Clinical Impact and Mechanisms of Response and Resistance","volume":"16","author":"Bagchi","year":"2021","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.xcrm.2025.101995_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib13","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41573-020-0077-5","article-title":"Targeting the epigenetic regulation of antitumour immunity","volume":"19","author":"Hogg","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2025.101995_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abj1270","article-title":"Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockade","volume":"14","author":"Stanczak","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2025.101995_bib15","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","article-title":"KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements","volume":"598","author":"Zhang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.101995_bib16","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature12751","article-title":"Chromatin proteins and modifications as drug targets","volume":"502","author":"Helin","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.101995_bib17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2014.05.016","article-title":"The mechanisms behind the therapeutic activity of BET bromodomain inhibition","volume":"54","author":"Shi","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.101995_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010061","article-title":"Reading Cancer: Chromatin Readers as Druggable Targets for Cancer Treatment","volume":"11","author":"Mio","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.xcrm.2025.101995_bib19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/2159-8290.CD-17-0605","article-title":"BET Proteins as Targets for Anticancer Treatment","volume":"8","author":"Stathis","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2025.101995_bib20","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1158\/0008-5472.CAN-13-0122-T","article-title":"BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy","volume":"73","author":"Segura","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib21","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1038\/s41467-020-15290-0","article-title":"Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction","volume":"11","author":"Yin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101995_bib22","doi-asserted-by":"crossref","first-page":"11428","DOI":"10.7150\/thno.47432","article-title":"BET inhibitor suppresses melanoma progression via the noncanonical NF-kappaB\/SPP1 pathway","volume":"10","author":"Deng","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.xcrm.2025.101995_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106609","article-title":"BRD4 inhibitor suppresses melanoma metastasis via the SPINK6\/EGFR-EphA2 pathway","volume":"187","author":"Hu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.celrep.2017.02.011","article-title":"BET-Bromodomain Inhibitors Engage the Host Immune System and Regulate Expression of the Immune Checkpoint Ligand PD-L1","volume":"18","author":"Hogg","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.101995_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.20892\/j.issn.2095-3941.2016.0020","article-title":"Nonmuscle invasive bladder cancer: a primer on immunotherapy","volume":"13","author":"Maruf","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.xcrm.2025.101995_bib26","doi-asserted-by":"crossref","first-page":"7903","DOI":"10.1007\/s00253-019-10057-0","article-title":"Mycobacterium bovis BCG in metastatic melanoma therapy","volume":"103","author":"Benitez","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.101995_bib27","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/joim.13037","article-title":"Clinical and molecular insights into BCG immunotherapy for melanoma","volume":"288","author":"Kremenovic","year":"2020","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.xcrm.2025.101995_bib28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.6004\/jnccn.2019.0018","article-title":"Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Coit","year":"2019","journal-title":"J.\u00a0Natl. Compr. Cancer Netw."},{"key":"10.1016\/j.xcrm.2025.101995_bib29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/CJI.0b013e31827457bd","article-title":"Combined intralesional Bacille Calmette-Guerin (BCG) and topical imiquimod for in-transit melanoma","volume":"35","author":"Kidner","year":"2012","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.xcrm.2025.101995_bib30","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00000658-197410000-00029","article-title":"BCG immunotherapy of malignant melanoma: summary of a seven-year experience","volume":"180","author":"Morton","year":"1974","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xcrm.2025.101995_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fonc.2017.00061","article-title":"Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by Mycobacterium bovis Bacille Calmette-Guerin","volume":"7","author":"Yang","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.xcrm.2025.101995_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fimmu.2017.00965","article-title":"Mycobacterium bovis Bacillus Calmette-Guerin Alters Melanoma Microenvironment Favoring Antitumor T Cell Responses and Improving M2 Macrophage Function","volume":"8","author":"Lardone","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.tcb.2021.07.001","article-title":"Cell cycle on the crossroad of tumorigenesis and cancer therapy","volume":"32","author":"Liu","year":"2022","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.xcrm.2025.101995_bib34","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/neuonc\/nov002","article-title":"Better see to better agree: phosphohistone H3 increases interobserver agreement in mitotic count for meningioma grading and imposes new specific thresholds","volume":"17","author":"Duregon","year":"2015","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.xcrm.2025.101995_bib35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4049\/jimmunol.1200061","article-title":"IFN-gamma from CD4 T\u00a0cells is essential for host survival and enhances CD8 T\u00a0cell function during Mycobacterium tuberculosis infection","volume":"190","author":"Green","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib36","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jaci.2007.06.023","article-title":"Role of regulatory T\u00a0cells and FOXP3 in human diseases","volume":"120","author":"Bacchetta","year":"2007","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.immuni.2014.11.012","article-title":"Granzyme B promotes cytotoxic lymphocyte transmigration via basement membrane remodeling","volume":"41","author":"Prakash","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2025.101995_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/jcp.27172","article-title":"PD-1\/PD-L1 immune checkpoint: Potential target for cancer therapy","volume":"234","author":"Dermani","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.xcrm.2025.101995_bib40","first-page":"4099","article-title":"Characterization of T-cell memory phenotype after in\u00a0vitro expansion of tumor-infiltrating\u00a0lymphocytes from melanoma patients","volume":"31","author":"Zhou","year":"2011","journal-title":"Anticancer Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib41","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.cell.2016.08.052","article-title":"A Distinct Gene Module for Dysfunction Uncoupled from Activation in Tumor-Infiltrating T Cells","volume":"166","author":"Singer","year":"2016","journal-title":"Cellule"},{"key":"10.1016\/j.xcrm.2025.101995_bib42","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1021\/acs.jmedchem.0c01487","article-title":"Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development","volume":"64","author":"Tang","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2025.101995_bib43","article-title":"BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma","volume":"10","author":"Kremenovic","year":"2022","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2025.101995_bib44","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1245\/s10434-017-6072-3","article-title":"Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma Metastases","volume":"24","author":"Faries","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.xcrm.2025.101995_bib45","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/toxsci\/52.2.199","article-title":"Metallothionein-induced suppression of cytotoxic T lymphocyte function: an important immunoregulatory control","volume":"52","author":"Youn","year":"1999","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.xcrm.2025.101995_bib46","article-title":"CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands","volume":"21","author":"Korbecki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2025.101995_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1126\/science.7682337","article-title":"Preferential migration of activated CD4+ and CD8+ T\u00a0cells in response to MIP-1 alpha and MIP-1 beta","volume":"260","author":"Taub","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101995_bib48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer. Cell."},{"key":"10.1016\/j.xcrm.2025.101995_bib49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation - A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.xcrm.2025.101995_bib50","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.trecan.2020.02.022","article-title":"Turning Cold into Hot: Firing up the Tumor Microenvironment","volume":"6","author":"Duan","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.xcrm.2025.101995_bib51","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","article-title":"Exploring the full spectrum of macrophage activation","volume":"8","author":"Mosser","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2025.101995_bib52","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.autrev.2008.12.002","article-title":"CXCL10 and autoimmune diseases","volume":"8","author":"Lee","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.xcrm.2025.101995_bib53","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.101995_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2025.101995_bib55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1186\/1471-2105-12-323","article-title":"RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome","volume":"12","author":"Li","year":"2011","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.101995_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cels.2018.11.005","article-title":"Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data","volume":"8","author":"Wolock","year":"2019","journal-title":"Cell Syst."},{"key":"10.1016\/j.xcrm.2025.101995_bib57","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.101995_bib58","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.101995_bib59","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells","volume":"32","author":"Trapnell","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.101995_bib60","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"key":"10.1016\/j.xcrm.2025.101995_bib61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41587-021-01206-w","article-title":"A Python library for probabilistic analysis of single-cell omics data","volume":"40","author":"Gayoso","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.101995_bib62","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","article-title":"A scalable SCENIC workflow for single-cell gene regulatory network analysis","volume":"15","author":"Van de Sande","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2025.101995_bib63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.101995_bib64","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nbt.1754","article-title":"Integrative genomics viewer","volume":"29","author":"Robinson","year":"2011","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.101995_bib65","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/pcmr.12996","article-title":"Establishment of cultured primary acral melanoma cells and animal models for Chinese patients","volume":"34","author":"Hu","year":"2021","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib66","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1093\/nar\/gky1173","article-title":"scFTD-seq: freeze-thaw lysis based, portable approach toward highly distributed single-cell 3' mRNA profiling","volume":"47","author":"Dura","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib67","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.xcrm.2025.101995_bib68","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation"},{"key":"10.1016\/j.xcrm.2025.101995_bib69","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/978-1-0716-1534-8_10","article-title":"Inference of Gene Regulatory Network from Single-Cell Transcriptomic Data Using pySCENIC","volume":"2328","author":"Kumar","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2025.101995_bib70","doi-asserted-by":"crossref","first-page":"W175","DOI":"10.1093\/nar\/gkac199","article-title":"ChIP-Atlas 2021 update: a data-mining suite for exploring epigenomic landscapes by fully integrating ChIP-seq, ATAC-seq and Bisulfite-seq data","volume":"50","author":"Zou","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.101995_bib71","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846255","article-title":"ChIP-Atlas: a data-mining suite powered by full integration of public ChIP-seq data","volume":"19","author":"Oki","year":"2018","journal-title":"EMBO Rep."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125000680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T02:57:20Z","timestamp":1742612240000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125000680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":71,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2666379125000680"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101995","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BET inhibitor in combination with BCG vaccine enhances antitumor efficacy and orchestrates T\u00a0cell reprogramming for melanoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.101995","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101995"}}